A checkpoint on innate myeloid cells in pulmonary arterial hypertension.
作者信息
Bryant Andrew J, Fu Chunhua, Lu Yuanquing, Brantly Mark L, Mehrad Borna, Moldawer Lyle L, Brusko Todd M, Brittain Evan L, West James D, Austin Eric D, Hamid Rizwan
机构信息
1 Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
2 Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA.
出版信息
Pulm Circ. 2019 Jan-Mar;9(1):2045894018823528. doi: 10.1177/2045894018823528. Epub 2018 Dec 18.
Abstract
摘要
相似文献
1
A checkpoint on innate myeloid cells in pulmonary arterial hypertension.
Pulm Circ. 2019 Jan-Mar;9(1):2045894018823528. doi: 10.1177/2045894018823528. Epub 2018 Dec 18.
2
Incident pulmonary arterial hypertension associated with Bosutinib.
Pulm Circ. 2020 Aug 21;10(3):2045894020936913. doi: 10.1177/2045894020936913. eCollection 2020 Jul-Sep.
3
Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.
Int J Mol Sci. 2018 Aug 3;19(8):2277. doi: 10.3390/ijms19082277.
4
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
5
Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
Pulm Circ. 2020 Nov 11;10(4):2045894020960967. doi: 10.1177/2045894020960967. eCollection 2020 Oct-Dec.
6
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Immunol Rev. 2017 Mar;276(1):145-164. doi: 10.1111/imr.12527.
7
Dasatinib-induced pulmonary arterial hypertension - A rare late complication.
J Oncol Pharm Pract. 2019 Apr;25(3):727-730. doi: 10.1177/1078155217753740. Epub 2018 Jan 17.
8
Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitors.
Immunotherapy. 2016 Jun;8(7):767-74. doi: 10.2217/imt-2016-0040.
9
Expression of checkpoint molecules on myeloid-derived suppressor cells.
Immunol Lett. 2017 Dec;192:1-6. doi: 10.1016/j.imlet.2017.10.001. Epub 2017 Oct 4.
10
Reversible pre-capillary pulmonary hypertension due to dasatinib.
Respir Care. 2014 May;59(5):e77-80. doi: 10.4187/respcare.02692. Epub 2013 Oct 22.
引用本文的文献
1
Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension.
JCI Insight. 2025 May 22;10(13). doi: 10.1172/jci.insight.184792. eCollection 2025 Jul 8.
2
Whole blood coagulation in an ex vivo thrombus is sufficient to induce clot neutrophils to adopt a myeloid-derived suppressor cell signature and shed soluble Lox-1.
J Thromb Haemost. 2024 Apr;22(4):1031-1045. doi: 10.1016/j.jtha.2023.12.014. Epub 2023 Dec 20.
3
Non-Interferon-Dependent Role of STING Signaling in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2024 Jan;44(1):124-142. doi: 10.1161/ATVBAHA.123.320121. Epub 2023 Nov 9.
4
Role of the Immune System Elements in Pulmonary Arterial Hypertension.
J Clin Med. 2021 Aug 23;10(16):3757. doi: 10.3390/jcm10163757.
5
KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
Int J Mol Sci. 2021 May 9;22(9):5014. doi: 10.3390/ijms22095014.
6
Biological drug and drug delivery-mediated immunotherapy.
Acta Pharm Sin B. 2021 Apr;11(4):941-960. doi: 10.1016/j.apsb.2020.12.018. Epub 2020 Dec 31.
7
The Third Man: DNA sensing as espionage in pulmonary vascular health and disease.
Pulm Circ. 2021 Mar 2;11(1):2045894021996574. doi: 10.1177/2045894021996574. eCollection 2021 Jan-Mar.
8
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling.
Br J Pharmacol. 2021 Jan;178(1):187-202. doi: 10.1111/bph.14945. Epub 2020 Feb 4.
本文引用的文献
1
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
J Clin Invest. 2018 Nov 1;128(11):5137-5149. doi: 10.1172/JCI96268. Epub 2018 Oct 15.
2
A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
PLoS One. 2018 Aug 30;13(8):e0202920. doi: 10.1371/journal.pone.0202920. eCollection 2018.
3
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Am J Respir Crit Care Med. 2018 Sep 15;198(6):777-787. doi: 10.1164/rccm.201708-1707OC.
4
Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.
Circ Res. 2018 Jun 8;122(12):1689-1702. doi: 10.1161/CIRCRESAHA.117.312058. Epub 2018 Mar 15.
5
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension.
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.01214-2017. Print 2018 Jan.
6
Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
Eur J Immunol. 2018 Mar;48(3):532-542. doi: 10.1002/eji.201746976. Epub 2017 Dec 8.
7
Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea.
Eur Respir J. 2017 Oct 19;50(4). doi: 10.1183/13993003.00833-2017. Print 2017 Oct.
8
Spleen-derived IFN-γ induces generation of PD-L1-suppressive neutrophils during endotoxemia.
J Leukoc Biol. 2017 Dec;102(6):1401-1409. doi: 10.1189/jlb.3A0217-051RR. Epub 2017 Oct 3.
9
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2018 Feb;58(2):170-180. doi: 10.1165/rcmb.2017-0214OC.
10
Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Am J Respir Cell Mol Biol. 2017 Aug;57(2):238-247. doi: 10.1165/rcmb.2016-0366OC.
Zotero 插件